Advertisement

Topics

Tetraphase nets $61.1mm via FOPO

15:40 EDT 31 Jul 2017 | Elsevier Business Intelligence

Infectious disease-focused Tetraphase Pharmaceuticals Inc. netted $61.1mm through a follow-on public offering of 10mm common ...

Original Article: Tetraphase nets $61.1mm via FOPO

NEXT ARTICLE

More From BioPortfolio on "Tetraphase nets $61.1mm via FOPO"

Quick Search
Advertisement
 

Relevant Topics

Infectious-diseases
Antiretroviral Therapy Clostridium Difficile Ebola HIV & AIDS Infectious Diseases Influenza Malaria Measles Sepsis Swine Flu Tropical Medicine Tuberculosis Infectious diseases are caused by pathogenic...

Clincial Trials
In a clinical trial or interventional study, participants receive specific interventions according to the research plan or protocol created by the investigators. These interventions may be medical products, such as drugs or devices; procedures; or change...